A00-B99 J00-J06 J09-J18 J20-J22 H65 R50 L00-L08 N30
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - The practice is approved by the Association of Statutory Health Insurance Physicians. - It is a pediatric practice (specialist group 34). - The practice uses the BVKJ Service Center practice app. - The practice agrees to participate in the study. Inclusion criteria for parents in the education program: - Treatment in one of the participating pediatric practices - Children are insured by a statutory health insurance fund - Legal guardians are at least 18 years of age - Legal guardians are able to understand the study documents (cognitively and linguistically) - Children under 6 years of age who have not undergone U9
Exclusion criteria
Exclusion criteria: - Practices specializing in pediatric surgery or other highly specialized areas without U examinations
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systemic antibiotic prescription rate as the number of all prescriptions per facility in 2027 divided by the number of children, born between 2021 and 2027 (age below < 6 years), who were treated in that year. | — |
Secondary
| Measure | Time frame |
|---|---|
| a.) Antipyretic prescription rate as the number of all prescriptions per facility in 2027 divided by the number of children, born between 2021 and 2027 (age below < 6 years), who were treated in that year Outcomes for a subgroup: b.) Proportion of children with at least one antibiotic prescription per facility in 2027 (based on the number of children born between 2021 and 2027 treated in that year) c.) Proportion of children with at least one antipyretic prescription per facility in 2027 (based on the number of children born between 2021 and 2027 treated in that year) d.) Antibiotic prescription rate as the number of all prescriptions per facility in 2027 in the presence of a defined diagnosis divided by the number of children born between 2021 and 2027 with a defined diagnosis (ICD-10 diagnoses (code G for verified): A00-B99 (certain infectious and parasitic diseases), J00-J06 (upper respiratory tract infections), J09-J18 (influenza and influenza-like illnesses), J19-J22 (chronic respiratory diseases), J23-J27 (chronic respiratory diseases, other), J28-J31 (chronic respiratory diseases, unspecified), J32-J35 (chronic respiratory diseases, unspecified, other), J3 A00-B99 (certain infectious and parasitic diseases), J00- J06 (upper respiratory tract infections), J09-J18 (influenza and pneumonia), J20-J22 (lower respiratory tract), H65-H67 (otitis media), R50 (fever), L00-L08 (skin infections) or N39, N30 (urinary tract infection). e.) Antipyretic prescription rate as the number of all prescriptions per facility in 2027 in the presence of a defined diagnosis divided by the number of children born between 2021 and 2027 with a defined diagnosis (ICD-10 diagnoses (code G for verified): A00-B99 (certain infectious and parasitic diseases), J00-J06 (upper respiratory tract infections), J09-J18 (influenza and influenza-like illnesses), J19-J22 (chronic respiratory diseases), J23-J27 (chronic respiratory diseases, other), J28-J31 (chronic respiratory diseases, uns | — |
Countries
Germany
Contacts
Private Universität Witten/Herdecke